Leukotriene B₄-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression

References

• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-867. doi:10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006;124:823-835. doi:10.1016/j.cell.2006.02.016. PMID:16497591
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436-444. doi:10.1038/nature07205. PMID:18650914
   PubMed Web of Science ®Google Scholar
• Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118, 285-296. doi:10.1016/j.cell.2004.07.013. PMID:15294155
   PubMed Web of Science ®Google Scholar
• Dzutsev A, Goldszmid RS, Viaud S, Zitvogel L, Trinchieri G. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. European Journal of Immunology. 2015;45:17-31. doi:10.1002/eji.201444972. PMID:25328099
   PubMed Web of Science ®Google Scholar
• Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nature Reviews Cancer. 2017;17(5):271-285. doi:10.1038/nrc.2017.13. PMID:28303904
   PubMed Web of Science ®Google Scholar
• Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65-80. doi:10.1053/j.gastro.2008.10.080. PMID:19026645
   PubMed Web of Science ®Google Scholar
• Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PloS One. 2011;6:e16393. doi:10.1371/journal.pone.0016393. PMID:21297998
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Jobin C. The microbiome and cancer. Nature Reviews Cancer. 2013;13:800-812. doi:10.1038/nrc3610. PMID:24132111
   PubMed Web of Science ®Google Scholar
• Vipperla K, O'Keefe SJ. The microbiota and its metabolites in colonic mucosal health and cancer risk. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition. 2012;27:624-635. doi:10.1177/0884533612452012. PMID:22868282
   PubMed Web of Science ®Google Scholar
• Waisberg J, Matheus Cde O, Pimenta J. Infectious endocarditis from Streptococcus bovis associated with colonic carcinoma: case report and literature review. Arq Gastroenterol. 2002;39:177-180. PMID:12778310
   PubMedGoogle Scholar
• Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004;139:760-765. doi:10.1001/archsurg.139.7.760. PMID:15249410
   PubMed Web of Science ®Google Scholar
• Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med. 1977;297:800-802. doi:10.1056/NEJM197710132971503. PMID:408687
   PubMed Web of Science ®Google Scholar
• Zarkin BA, Lillemoe KD, Cameron JL, Effron PN, Magnuson TH, Pitt HA. The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg. 1990;211:786-791; discussion 791-782. PMID:2357141
   PubMed Web of Science ®Google Scholar
• Ruoff KL, Miller SI, Garner CV, Ferraro MJ, Calderwood SB. Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol 1989;27:305-308 PMID:2915024
   PubMed Web of Science ®Google Scholar
• Tsuji S, Tsujii M, Murata H, Nishida T, Komori M, Yasumaru M, Ishii S, Sasayama Y, Kawano S, Hayashi N. Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms. World J Gastroenterol. 2006;12:1671-1680. PMID:16586533
   PubMed Web of Science ®Google Scholar
• Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 2003;125:1636-1644. PMID:14724815
   PubMed Web of Science ®Google Scholar
• Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127:80-93. PMID:15236175
   PubMed Web of Science ®Google Scholar
• Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PloS One. 2012;7:e39743. doi:10.1371/journal.pone.0039743. PMID:22761885
   PubMed Web of Science ®Google Scholar
• Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci. 2007;120:3327-3335. doi:10.1242/jcs.03485. PMID:17881494
   PubMed Web of Science ®Google Scholar
• Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990;247:322-324. PMID:2296722
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science. 2007;317:124-127. doi:10.1126/science.1140488. PMID:17615359
   PubMed Web of Science ®Google Scholar
• Toda A, Yokomizo T, Shimizu T. Leukotriene B4 receptors. Prostaglandins & Other Lipid Mediators. 2002;68-69:575-585.
   PubMed Web of Science ®Google Scholar
• Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature. 1997;387:620-624. doi:10.1038/42506. PMID:9177352
   PubMed Web of Science ®Google Scholar
• Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. The Journal of Experimental Medicine. 2000;192:421-432. PMID:10934230
   PubMed Web of Science ®Google Scholar
• Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nature Immunology. 2003;4:982-990. doi:10.1038/ni970. PMID:12949531
   PubMed Web of Science ®Google Scholar
• Subbarao K, Jala VR, Mathis S, Suttles J, Zacharias W, Ahamed J, Ali H, Tseng MT, Haribabu B. Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol. 2004;24:369-375. doi:10.1161/01.ATV.0000110503.16605.15. PMID:14656734
   PubMed Web of Science ®Google Scholar
• Miyahara N, Takeda K, Miyahara S, Matsubara S, Koya T, Joetham A, Krishnan E, Dakhama A, Haribabu B, Gelfand EW. Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness. American Journal Of Respiratory And Critical Care Medicine. 2005;172:161-167. doi:10.1164/rccm.200502-205OC. PMID:15849325
   PubMed Web of Science ®Google Scholar
• Kim ND, Chou RC, Seung E, Tager AM, Luster AD. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. The Journal of Experimental Medicine. 2006;203:829-835. doi:10.1084/jem.20052349. PMID:16567386
   PubMed Web of Science ®Google Scholar
• Shao WH, Del Prete A, Bock CB, Haribabu B. Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice. Journal of Immunology. 2006;176:6254-6261.
   PubMed Web of Science ®Google Scholar
• Houthuijzen JM, Daenen LG, Roodhart JM, Oosterom I, van Jaarsveld MT, Govaert KM, Smith ME, Sadatmand SJ, Rosing H, Kruse F, et al. Lysophospholipids secreted by splenic macrophages induce chemotherapy resistance via interference with the DNA damage response. Nat Commun. 2014;5:5275. doi:10.1038/ncomms6275. PMID:25387467
   PubMed Web of Science ®Google Scholar
• Haribabu B, Verghese MW, Steeber DA, Sellars DD, Bock CB, Snyderman R. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J Exp Med. 2000;192:433-438. PMID:10934231
   PubMed Web of Science ®Google Scholar
• Marr KA, Balajee SA, Hawn TR, Ozinsky A, Pham U, Akira S, Aderem A, Liles WC. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun. 2003;71:5280-5286. PMID:12933875
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nature Methods. 2010;7:335-336. doi:10.1038/nmeth.f.303. PMID:20383131
   PubMed Web of Science ®Google Scholar
• Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. UniFrac: an effective distance metric for microbial community comparison. The ISME Journal 2011;5:169-172. doi:10.1038/ismej.2010.133. PMID:20827291
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408. doi:10.1006/meth.2001.1262. PMID:11846609
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159-170. PMID:8861899
   PubMed Web of Science ®Google Scholar
• Humphries A, Wright NA. Colonic crypt organization and tumorigenesis. Nat Rev Cancer. 2008;8:415-424. doi:10.1038/nrc2392. PMID:18480839
   PubMed Web of Science ®Google Scholar
• Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749-759. doi:10.1038/nri1703. PMID:16175180
   PubMed Web of Science ®Google Scholar
• Williams CS, et al. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology. 1996;111:1134-1140. doi: S0016-5085(96)70083-5. PMID:8831610
   PubMed Web of Science ®Google Scholar
• Carlin JM, Borden EC, Byrne GI. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J Interferon Res 1989;9:329-337. PMID:2501398
   PubMedGoogle Scholar
• Thomas SM, Garrity LF, Brandt CR, Schobert CS, Feng GS, Taylor MW, Carlin JM, Byrne GI. IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J Immunol. 1993;150:5529-5534 PMID:8515074
   PubMed Web of Science ®Google Scholar
• Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol. 2003;4:269-273. doi:10.1038/ni888ni888. PMID:12548285
   PubMed Web of Science ®Google Scholar
• Boix E, Nogues MV. Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence. Mol Biosyst. 2007;3:317-335. doi:10.1039/b617527a. PMID:17460791
   PubMed Web of Science ®Google Scholar
• Rosenberg HF. RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol. 2008;83:1079-1087. doi:10.1189/jlb.1107725. PMID:18211964
   PubMed Web of Science ®Google Scholar
• Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313:1126-1130. doi:10.1126/science.1127119. PMID:16931762
   PubMed Web of Science ®Google Scholar
• Soares EM, Mason KL, Rogers LM, Serezani CH, Faccioli LH, Aronoff DM. Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes. Journal of Immunology. 2013;190:1614-1622. doi:10.4049/jimmunol.1202932
   PubMed Web of Science ®Google Scholar
• Sorgi CA, Secatto A, Fontanari C, Turato WM, Belangér C, de Medeiros AI, Kashima S, Marleau S, Covas DT, Bozza PT, et al. Histoplasma capsulatum cell wall {beta}-glucan induces lipid body formation through CD18, TLR2, and dectin-1 receptors: correlation with leukotriene B4 generation and role in HIV-1 infection. Journal of Immunology. 2009;182:4025-4035. doi:10.4049/jimmunol.0801795
   PubMed Web of Science ®Google Scholar
• Gaudreault E, Gosselin J. Leukotriene B4-mediated release of antimicrobial peptides against cytomegalovirus is BLT1 dependent. Viral Immunology. 2007;20:407-420. doi:10.1089/vim.2006.0099. PMID:17931111
   PubMed Web of Science ®Google Scholar
• Serezani CH, Perrela JH, Russo M, Peters-Golden M, Jancar S. Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. Journal Of Immunology. 2006;177:3201-3208.
   PubMed Web of Science ®Google Scholar
• Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317:121-124. doi:10.1126/science.1140485. PMID:17615358
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung K, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature. 2012;491:254-258. doi:10.1038/nature11465 PMID:23034650
   PubMed Web of Science ®Google Scholar
• Satpathy SR, Jala VR, Bodduluri SR, Krishnan E, Hegde B, Hoyle GW, Fraig M, Luster AD, Haribabu B. Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth. Nat Commun. 2015;6:7064. doi:10.1038/ncomms8064. PMID:25923988
   PubMed Web of Science ®Google Scholar
• Hong KH, Bonventre JC, O'Leary E, Bonventre JV, Lander ES. Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis. Proc Natl Acad Sci U S A. 2001;98:3935-3939. doi:10.1073/pnas.051635898. PMID:11274413
   PubMed Web of Science ®Google Scholar
• Kawai N, Tsujii M, Tsuji S. Cyclooxygenases and colon cancer. Prostaglandins & Other Lipid Mediators. 2002;68-69:187-196.
   PubMed Web of Science ®Google Scholar
• Wang D, Wang H, Shi Q, Katkuri S, Walhi W, Desvergne B, Das SK, Dey SK, DuBois RN. Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell. 2004;6:285-295. doi:10.1016/j.ccr.2004.08.011. PMID:15380519
   PubMed Web of Science ®Google Scholar
• Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996;87:803-809. doi: S0092-8674(00)81988-1. PMID:8945508
   PubMed Web of Science ®Google Scholar
• Mohammed A, Janakiram NB, Li Q, Choi CI, Zhang Y, Steele VE, Rao CV. Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention. Cancer Prevention Research. 2011;4:2015-2026. doi:10.1158/1940-6207.CAPR-11-0233. PMID:21885812
   PubMed Web of Science ®Google Scholar
• Cheon EC, Khazaie K, Khan MW, Strouch MJ, Krantz SB, Phillips J, Blatner NR, Hix LM, Zhang M, Dennis KL, et al. Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APCDelta468 mice. Cancer Research. 2011;71:1627-1636. doi:10.1158/0008-5472.CAN-10-1923. PMID:21216893
   PubMed Web of Science ®Google Scholar
• Mehdawi L, Osman J, Topi G, Sjolander A. High tumor mast cell density is associated with longer survival of colon cancer patients. Acta Oncol. 2016;55:1434-1442. doi:10.1080/0284186X.2016.1198493. PMID:27355473
   PubMed Web of Science ®Google Scholar
• Dreyling KW, Hoppe U, Peskar BA, Morgenroth K, Kozuschek W, Peskar BM. Leukotriene synthesis by human gastrointestinal tissues. Biochim Biophys Acta. 1986;878:184-193. PMID:3019409
   PubMed Web of Science ®Google Scholar
• Chiu CH, McEntee MF, Whelan J. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Research. 1997;57:4267-4273. PMID:9331087
   PubMed Web of Science ®Google Scholar
• Flamand L, Tremblay MJ, Borgeat P. Leukotriene B4 triggers the in vitro and in vivo release of potent antimicrobial agents. Journal of Immunology. 2007;178:8036-8045. doi: 178/12/8036
   PubMed Web of Science ®Google Scholar
• Gaudreault E, Gosselin J. Leukotriene B4 induces release of antimicrobial peptides in lungs of virally infected mice. Journal of Immunology 2008;180:6211-6221. doi: 180/9/6211
   PubMed Web of Science ®Google Scholar
• Scott MJ, Cheadle WG, Hoth JJ, Peyton JC, Subbarao K, Shao WH, Haribabu B. Leukotriene B4 receptor (BLT-1) modulates neutrophil influx into the peritoneum but not the lung and liver during surgically induced bacterial peritonitis in mice. Clinical and Diagnostic Laboratory Immunology. 2004;11:936-941. doi:10.1128/CDLI.11.5.936-941.2004. PMID:15358656
   PubMedGoogle Scholar
• Mancuso P, Standiford TJ, Marshall T, Peters-Golden M. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun. 1998;66:5140-5146. PMID:9784515
   PubMed Web of Science ®Google Scholar
• Sharma RK, Chheda Z, Jala VR, Haribabu B. Expression of Leukotriene B4 Receptor-1 on CD8+ T Cells is required for their migration into tumors to elicit effective antitumor immunity. Journal of Immunology 2013;191:3462-3470. doi:10.4049/jimmunol.1300967
   PubMed Web of Science ®Google Scholar
• Chheda ZS, Sharma RK, Jala VR, Luster AD, Haribabu B. Chemoattractant receptors BLT1 and CXCR3 regulate antitumor immunity by facilitating CD8+ T Cell migration into tumors. J Immunol. 2016;197:2016-2026. doi:10.4049/jimmunol.1502376. PMID:27465528
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39:782-795. doi:10.1016/j.immuni.2013.10.003. PMID:24138885
   PubMed Web of Science ®Google Scholar
• Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature. 2008;455:1109-1113. doi:10.1038/nature07336. PMID:18806780
   PubMed Web of Science ®Google Scholar
• Lee SH, Hu LL, Gonzalez-Navajas J, Seo GS, Shen C, Brick J, Herdman S, Varki N, Corr M, Lee J, et al. ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nature Medicine. 2010;16:665-670. doi:10.1038/nm.2143. PMID:20473309
   PubMed Web of Science ®Google Scholar
• Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O'hUigin C, et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. The Journal of Experimental Medicine. 2010;207:1625-1636. doi:10.1084/jem.20100199. PMID:20624890
   PubMed Web of Science ®Google Scholar
• Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Med. 2011;3:14. doi:10.1186/gm228. PMID:21392406
   PubMed Web of Science ®Google Scholar
• Chung H, Kasper DL. Microbiota-stimulated immune mechanisms to maintain gut homeostasis. Curr Opin Immunol. 2010;22;455-460. doi:10.1016/j.coi.2010.06.008. PMID:20656465
   PubMed Web of Science ®Google Scholar
• Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science. 2010;330:1768-1773. doi:10.1126/science.1195568. PMID:21205662
   PubMed Web of Science ®Google Scholar
• Kuczynski J, Costello EK, Nemergut DR, Zaneveld J, Lauber CL, Knights D, Koren O, Fierer N, Kelley ST, Ley RE, et al. Direct sequencing of the human microbiome readily reveals community differences. Genome Biol. 2010;11:210. doi:10.1186/gb-2010-11-5-210. PMID:20441597
   PubMed Web of Science ®Google Scholar
• Arthur JC, Jobin C. The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis. 2011;17:396-409. doi:10.1002/ibd.21354. PMID:20848537
   PubMed Web of Science ®Google Scholar
• Candela M, Guidotti M, Fabbri A, Brigidi P, Franceschi C, Fiorentini C. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit Rev Microbiol. 2011;37:1-14. doi:10.3109/1040841X.2010.501760. PMID:20874522
   PubMed Web of Science ®Google Scholar
• Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, et al. Evolution of mammals and their gut microbes. Science. 2008;320:1647-1651. doi:10.1126/science.1155725. PMID:18497261
   PubMed Web of Science ®Google Scholar
• Belizario JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol. 2015;6:1050. doi:10.3389/fmicb.2015.01050. PMID:26500616
   PubMed Web of Science ®Google Scholar
• Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International Journal of Systematic and Evolutionary Microbiology. 2004;54:1469-1476. doi:10.1099/ijs.0.02873-0. PMID:15388697
   PubMed Web of Science ®Google Scholar
• Collado MC, Derrien M, Isolauri E, de Vos WM, Salminen S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Applied and Environmental Microbiology. 2007;73:7767-7770. doi:10.1128/AEM.01477-07. PMID:17933936
   PubMed Web of Science ®Google Scholar
• Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM. The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Applied and Environmental Microbiology. 2008;74:1646-1648. doi:10.1128/AEM.01226-07. PMID:18083887
   PubMed Web of Science ®Google Scholar
• Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults. PloS One. 2013;8:e70803. doi:10.1371/journal.pone.0070803. PMID:23940645
   PubMed Web of Science ®Google Scholar
• Zella GC, Hait EJ, Glavan T, Gevers D, Ward DV, Kitts CL, Korzenik JR. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflammatory Bowel Diseases. 2011;17:1092-1100. doi:10.1002/ibd.21460. PMID:20845425
   PubMed Web of Science ®Google Scholar
• Yang K, Popova NV, Yang WC, Lozonschi I, Tadesse S, Kent S, Bancroft L, Matise I, Cormier RT, Scherer SJ, et al. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer Res. 2008. 68:7313-7322. doi:10.1158/0008-5472.CAN-08-0598. PMID:18794118
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140:771-776. doi:10.1016/j.cell.2010.03.006. PMID:20303867
   PubMed Web of Science ®Google Scholar